首頁 > 市場調查報告書 > 醫療設備

體外診斷癌症癌症診斷

市場調查報告書

商品編碼

1905400

日本癌症診斷市場報告（按產品、技術、應用、最終用戶和地區分類，2026-2034年）

Japan Cancer Diagnostics Market Report by Product, Technology, Application, End User, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 122 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本癌症診斷市場規模達14億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到38億美元，2026年至2034年期間的複合年成長率（CAGR）為11.59%。生活方式改變和遺傳因素導致癌症發病率上升，以及診斷方法的進步改善患者護理，是推動市場成長的主要因素。

本報告解答的關鍵問題：

日本癌症診斷市場目前的表現如何？未來幾年又將如何發展？
新冠疫情對日本癌症診斷市場產生了哪些影響？
日本癌症診斷市場依產品分類的組成是怎樣的？
日本癌症診斷市場依技術分類的組成是怎樣的？
日本癌症診斷市場按應用領域分類的組成是怎樣的？
日本癌症診斷市場依最終用戶分類的組成是怎樣的？
日本癌症診斷市場價值鏈的各個階段有哪些？
日本癌症診斷的關鍵促進因素和挑戰是什麼？
日本癌症診斷市場的結構是怎麼樣的？主要參與者有哪些？
日本癌症診斷市場的競爭程度如何？

Japan cancer diagnostics market size reached USD 1.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2034, exhibiting a growth rate (CAGR) of 11.59% during 2026-2034. The rising incidence of cancer, due to lifestyle shifts and genetic factors, and the development of diagnostic methods to improve patient care are among the primary drivers of the market growth.

Cancer diagnostics involve the identification and characterization of cancer in individuals, encompassing various methods and technologies like magnetic resonance imaging (MRI), X-rays, and laboratory examinations of blood, tissue, and genetic samples. These diagnostic tools enable healthcare experts to precisely detect and evaluate cancerous conditions within the body, facilitating accurate assessments. Additionally, they empower healthcare providers to customize treatments based on the unique attributes of the disease, thereby optimizing patient outcomes. This approach aids in refining treatment choices and crafting personalized therapeutic approaches.

Japan Cancer Diagnostics Market Trends:

In Japan's cancer diagnostics market, there is a notable surge in cancer cases driven by a multitude of factors, including shifts in lifestyle patterns, environmental influences, an aging population, and genetic predisposition. Accumulated genetic mutations and prolonged exposure to potential carcinogens have resulted in a rising incidence of cancer among the populace. Furthermore, unhealthy lifestyle choices such as poor dietary habits and limited physical activity are contributing to an increased risk of cancer. Notably, there is a growing inclination towards early detection as a means to enhance the effectiveness of cancer treatment. The heightened demand for precise and timely cancer diagnosis to prevent complications further fuels market expansion. Additionally, the improved accessibility to healthcare services plays a pivotal role in boosting market growth within Japan. The Japan cancer diagnostics market is further experiencing growth driven by an increasing awareness among consumers regarding the significance of early cancer detection. People are actively pursuing routine screenings and diagnostic examinations to proactively monitor their health status. Additionally, healthcare providers and organizations are conducting extensive awareness campaigns aimed at educating the public about the advantages of early intervention, thereby encouraging proactive healthcare-seeking behavior. Furthermore, early detection not only enhances treatment outcomes but also reduces the overall healthcare burden associated with advanced-stage cancer. Regulatory authorities and healthcare institutions in various countries are implementing accessible screening programs and emphasizing the importance of timely cancer diagnosis. These initiatives are motivating individuals to undergo regular cancer screenings, which is expected to fuel the regional market over the forecasted period.

Japan Cancer Diagnostics Market Segmentation:

Product Insights:

Consumables
- Antibodies
- Kits and Reagents
- Probes
- Others
Instruments
- Pathology-based Instruments
- Imaging Instruments
- Biopsy Instruments

Technology Insights:

IVD Testing
- Polymerase Chain Reaction (PCR)
- In Situ Hybridization (ISH)
- Immunohistochemistry (IHC)
- Next-generation Sequencing (NGS)
- Microarrays
- Flow Cytometry
- Immunoassays
- Others
Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Mammography
- Ultrasound
Biopsy Technique

Application Insights:

Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others

End User Insights:

Hospitals and Clinics
Diagnostic Laboratories
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan cancer diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan cancer diagnostics market?
What is the breakup of the Japan cancer diagnostics market on the basis of product?
What is the breakup of the Japan cancer diagnostics market on the basis of technology?
What is the breakup of the Japan cancer diagnostics market on the basis of application?
What is the breakup of the Japan cancer diagnostics market on the basis of end user?
What are the various stages in the value chain of the Japan cancer diagnostics market?
What are the key driving factors and challenges in the Japan cancer diagnostics?
What is the structure of the Japan cancer diagnostics market and who are the key players?
What is the degree of competition in the Japan cancer diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Cancer Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Cancer Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Cancer Diagnostics Market - Breakup by Product

6.1 Consumables
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Antibodies
  - 6.1.3.2 Kits and Reagents
  - 6.1.3.3 Probes
  - 6.1.3.4 Others
- 6.1.4 Market Forecast (2026-2034)
6.2 Instruments
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Pathology-based Instruments
  - 6.2.3.2 Imaging Instruments
  - 6.2.3.3 Biopsy Instruments
- 6.2.4 Market Forecast (2026-2034)

7 Japan Cancer Diagnostics Market - Breakup by Technology

7.1 IVD Testing
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Segmentation
  - 7.1.3.1 Polymerase Chain Reaction (PCR)
  - 7.1.3.2 In Situ Hybridization (ISH)
  - 7.1.3.3 Immunohistochemistry (IHC)
  - 7.1.3.4 Next-generation Sequencing (NGS)
  - 7.1.3.5 Microarrays
  - 7.1.3.6 Flow Cytometry
  - 7.1.3.7 Immunoassays
  - 7.1.3.8 Others
- 7.1.4 Market Forecast (2026-2034)
7.2 Imaging
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Segmentation
  - 7.2.3.1 Magnetic Resonance Imaging (MRI)
  - 7.2.3.2 Computed Tomography (CT)
  - 7.2.3.3 Positron Emission Tomography (PET)
  - 7.2.3.4 Mammography
  - 7.2.3.5 Ultrasound
- 7.2.4 Market Forecast 2026-2034
7.3 Biopsy Technique
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)

8 Japan Cancer Diagnostics Market - Breakup by Application

8.1 Breast Cancer
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Lung Cancer
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Colorectal Cancer
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)
8.4 Melanoma
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Forecast (2026-2034)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2020-2025)
- 8.5.2 Market Forecast (2026-2034)

9 Japan Cancer Diagnostics Market - Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2020-2025)
- 9.3.2 Market Forecast (2026-2034)

10 Japan Cancer Diagnostics Market - Breakup by Region

10.1 Kanto Region
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Breakup by Product
- 10.1.4 Market Breakup by Technology
- 10.1.5 Market Breakup by Application
- 10.1.6 Market Breakup by End User
- 10.1.7 Key Players
- 10.1.8 Market Forecast (2026-2034)
10.2 Kansai/Kinki Region
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Breakup by Product
- 10.2.4 Market Breakup by Technology
- 10.2.5 Market Breakup by Application
- 10.2.6 Market Breakup by End User
- 10.2.7 Key Players
- 10.2.8 Market Forecast (2026-2034)
10.3 Central/ Chubu Region
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Breakup by Product
- 10.3.4 Market Breakup by Technology
- 10.3.5 Market Breakup by Application
- 10.3.6 Market Breakup by End User
- 10.3.7 Key Players
- 10.3.8 Market Forecast (2026-2034)
10.4 Kyushu-Okinawa Region
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Breakup by Product
- 10.4.4 Market Breakup by Technology
- 10.4.5 Market Breakup by Application
- 10.4.6 Market Breakup by End User
- 10.4.7 Key Players
- 10.4.8 Market Forecast (2026-2034)
10.5 Tohoku Region
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2020-2025)
- 10.5.3 Market Breakup by Product
- 10.5.4 Market Breakup by Technology
- 10.5.5 Market Breakup by Application
- 10.5.6 Market Breakup by End User
- 10.5.7 Key Players
- 10.5.8 Market Forecast (2026-2034)
10.6 Chugoku Region
- 10.6.1 Overview
- 10.6.2 Historical and Current Market Trends (2020-2025)
- 10.6.3 Market Breakup by Product
- 10.6.4 Market Breakup by Technology
- 10.6.5 Market Breakup by Application
- 10.6.6 Market Breakup by End User
- 10.6.7 Key Players
- 10.6.8 Market Forecast (2026-2034)
10.7 Hokkaido Region
- 10.7.1 Overview
- 10.7.2 Historical and Current Market Trends (2020-2025)
- 10.7.3 Market Breakup by Product
- 10.7.4 Market Breakup by Technology
- 10.7.5 Market Breakup by Application
- 10.7.6 Market Breakup by End User
- 10.7.7 Key Players
- 10.7.8 Market Forecast (2026-2034)
10.8 Shikoku Region
- 10.8.1 Overview
- 10.8.2 Historical and Current Market Trends (2020-2025)
- 10.8.3 Market Breakup by Product
- 10.8.4 Market Breakup by Technology
- 10.8.5 Market Breakup by Application
- 10.8.6 Market Breakup by End User
- 10.8.7 Key Players
- 10.8.8 Market Forecast (2026-2034)

11 Japan Cancer Diagnostics Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Cancer Diagnostics Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis